Although uncommon, this side effect of radiation with adjuvant drug therapy is unpredictable, sometimes delayed, and can occur with administration of antibiotics and other drugs as well as chemotherapy.
The journal Science named cancer immunotherapy as "the breakthrough of the year"; but challenges still remain to overcome tumor immune suppression and genomic instability.
Helping patients understand that CAM products and dietary supplements may impede their cancer treatment is an essential part of patient education.
Soy and soy isoflavones are alleviating skin and lung toxicities from thoracic radiotherapy in preclinical study models; however, researchers stress the need for further studies.
Respiratory motion management reduces radiation exposure to nontarget tissues in patients undergoing treatment of cancers in the chest and abdomen.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|